STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 100 filers reported holding STEMLINE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 5.69 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $16,200,000 | -56.5% | 3,347,141 | -4.4% | 2.56% | -39.2% |
| Q4 2019 | $37,205,000 | +38.4% | 3,500,000 | +35.5% | 4.20% | +70.6% |
| Q3 2019 | $26,883,000 | -37.9% | 2,582,433 | -8.6% | 2.46% | -27.7% |
| Q2 2019 | $43,301,000 | +12.1% | 2,826,404 | -5.9% | 3.41% | -5.4% |
| Q1 2019 | $38,614,000 | – | 3,005,000 | – | 3.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 475,200 | $6,877,000 | 3.03% |
| Avoro Capital Advisors LLC | 475,000 | $6,873,000 | 2.64% |
| VHCP Management, LLC | 451,400 | $6,532,000 | 1.50% |
| Sio Capital Management, LLC | 140,000 | $2,026,000 | 1.15% |
| Opus Point Partners Management, LLC | 75,000 | $1,085,000 | 0.91% |
| Eventide Asset Management | 620,200 | $8,974,000 | 0.68% |
| Telemetry Investments, L.L.C. | 55,000 | $796,000 | 0.44% |
| Healthcare Value Capital, LLC | 25,000 | $362,000 | 0.40% |
| TFS CAPITAL LLC | 259,916 | $3,761,000 | 0.37% |
| FARALLON CAPITAL MANAGEMENT LLC | 672,562 | $9,732,000 | 0.14% |